The Biomedical Sciences Industry Partnership Office (BMS IPO) is a new joint initiative by the Economic Development Board (EDB), Agency for Science, Technology and Research (A*STAR) and the Ministry of Health (MOH). IPO aims to provide dedicated support to companies that have made significant funding commitments for R&D collaborations with Singapore-based investigators across multiple research institutions. It is the single Singapore point of contact for such companies, to introduce them to the local research landscape and to accelerate the establishing of research partnerships.
The Biomedical Sciences Industry Partnership Office (BMS IPO) is a new joint initiative by the Economic Development Board (EDB), Agency for Science, Technology and Research (A*STAR) and the Ministry of Health (MOH). IPO aims to provide dedicated support to companies that have made significant funding commitments for R&D collaborations with Singapore-based investigators across multiple research institutions. It is the single Singapore point of contact for such companies, to introduce them to the local research landscape and to accelerate the establishing of research partnerships.
The Biomedical Sciences Industry Partnership Office (BMS IPO) is a new joint initiative by the Economic Development Board (EDB), Agency for Science, Technology and Research (A*STAR) and the Ministry of Health (MOH). IPO aims to provide dedicated support to companies that have made significant funding commitments for R&D collaborations with Singapore-based investigators across multiple research institutions. It is the single Singapore point of contact for such companies, to introduce them to the local research landscape and to accelerate the establishing of research partnerships.